Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Subtle mucosal changes at capsule endoscopy in diarrhoea predominant Irritable Bowel Syndrome.

Kalla R, McAlindon ME, Sanders DS, Sidhu R.

Med Hypotheses. 2012 Sep;79(3):423. doi: 10.1016/j.mehy.2012.05.038. Epub 2012 Jul 4. No abstract available.

PMID:
22766519
2.

Erythrocyte sedimentation rate - possible role in determining the existence of the low grade inflammation in Irritable Bowel Syndrome patients.

Hauser G, Tkalcic M, Pletikosic S, Grabar N, Stimac D.

Med Hypotheses. 2012 Jun;78(6):818-20. doi: 10.1016/j.mehy.2012.03.020. Epub 2012 Apr 16.

PMID:
22513237
3.

Histopathological alterations in irritable bowel syndrome.

Kirsch R, Riddell RH.

Mod Pathol. 2006 Dec;19(12):1638-45. Epub 2006 Sep 29. Review. Erratum in: Mod Pathol. 2007 Feb;20(2):278. Kirsch, Richard H [corrected to Kirsch, Richard]; Riddell, Robert [corrected to Riddell, Robert H].

4.

[Current views of the pathogenesis of irritable bowel syndrome].

Zhukov NA, Sorokina EA, Akhmedov VA, Trem'iakova TV.

Klin Med (Mosk). 2003;81(12):7-13. Review. Russian.

PMID:
14971149
5.
6.

A prospective evaluation of the diagnostic value of video capsule endoscopy in patients initially classified as irritable bowel syndrome.

Ohlsson B, Bengtsson M, Nielsen J, Toth E.

Eur J Intern Med. 2009 Jan;20(1):48-52. doi: 10.1016/j.ejim.2008.04.018. Epub 2008 Jun 10.

PMID:
19237092
7.

Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.

Ford AC, Talley NJ.

J Gastroenterol. 2011 Apr;46(4):421-31. doi: 10.1007/s00535-011-0379-9. Epub 2011 Feb 18. Review.

PMID:
21331765
8.

Are symptomatic changes in irritable bowel syndrome correlated with the capsule endoscopy transit time? A pilot study using the 5-HT4 receptor agonist mosapride.

Nakamura M, Ohmiya N, Miyahara R, Ando T, Watanabe O, Kawashima H, Itoh A, Hirooka Y, Niwa Y, Goto H.

Hepatogastroenterology. 2011 Mar-Apr;58(106):453-8.

PMID:
21661412
9.

New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

Ohman L, Simrén M.

Dig Liver Dis. 2007 Mar;39(3):201-15. Epub 2007 Jan 30. Review.

PMID:
17267314
10.

Changes in intestinal motility, visceral sensitivity and minor mucosal inflammation after fasting therapy in a patient with irritable bowel syndrome.

Kano M, Fukudo S, Kanazawa M, Endo Y, Narita H, Tamura D, Hongo M.

J Gastroenterol Hepatol. 2006 Jun;21(6):1078-9. No abstract available.

PMID:
16725003
11.

Overlap between irritable bowel syndrome and inflammatory bowel disease.

Spiller RC.

Dig Dis. 2009;27 Suppl 1:48-54. doi: 10.1159/000268121. Epub 2010 Mar 4.

PMID:
20203497
12.

A closer look at mucosal inflammation in irritable bowel syndrome: sex- and gender-related disparities--quantity, quality, or both?

Alonso C, Santos J.

Am J Gastroenterol. 2009 Feb;104(2):401-3. doi: 10.1038/ajg.2008.105. Epub 2009 Jan 13.

PMID:
19174802
13.

Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.

Ersryd A, Posserud I, Abrahamsson H, Simrén M.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):953-61.

14.

[Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope].

Kong WM, Gong J, Dong L, Chen MX.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1167-70, 1172. Chinese.

15.

Postinfectious irritable bowel syndrome.

DuPont AW.

Clin Infect Dis. 2008 Feb 15;46(4):594-9. doi: 10.1086/526774. Review.

16.

Mucosal mast cells in irritable bowel syndrome and inflammatory bowel disease.

Tunc B, Filik L, Altintaş E, Turhan N, Ulker A, Dağli U.

Acta Medica (Hradec Kralove). 2005;48(3-4):163-4.

17.

The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.

Kilkens TO, Honig A, Fekkes D, Brummer RJ.

Aliment Pharmacol Ther. 2005 Nov 1;22(9):865-74.

18.

The effects of exercise upon symptoms and quality of life in patients diagnosed with irritable bowel syndrome: a randomised controlled trial.

Daley AJ, Grimmett C, Roberts L, Wilson S, Fatek M, Roalfe A, Singh S.

Int J Sports Med. 2008 Sep;29(9):778-82. doi: 10.1055/s-2008-1038600. Epub 2008 May 6.

PMID:
18461499
19.

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):71-8.

PMID:
16706815
20.

Is irritable bowel syndrome an inflammatory disorder?

De Giorgio R, Barbara G.

Curr Gastroenterol Rep. 2008 Aug;10(4):385-90. Review.

PMID:
18627650
Items per page

Supplemental Content

Write to the Help Desk